| Literature DB >> 17229882 |
Lia M Haynes1, Congrong Miao, Jennifer L Harcourt, Joel M Montgomery, Mai Quynh Le, Sergey A Dryga, Kurt I Kamrud, Bryan Rivers, Gregory J Babcock, Jennifer Betts Oliver, James A Comer, Mary Reynolds, Timothy M Uyeki, Daniel Bausch, Thomas Ksiazek, William Thomas, Harold Alterson, Jonathan Smith, Donna M Ambrosino, Larry J Anderson.
Abstract
Recombinant severe acute respiratory syndrome (SARS) nucleocapsid and spike protein-based immunoglobulin G immunoassays were developed and evaluated. Our assays demonstrated high sensitivity and specificity to the SARS coronavirus in sera collected from patients as late as 2 years postonset of symptoms. These assays will be useful not only for routine SARS coronavirus diagnostics but also for epidemiological and antibody kinetic studies.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17229882 PMCID: PMC1828864 DOI: 10.1128/CVI.00351-06
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X